Back to Search
JEFFREY SCHAPIRO, MD
MD
Infectious Disease Physician
NPI: 1235217803Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
G87148(CA)
Research & Publications (20)
Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.
PMID 15364999·J Clin Microbiol·2004
5-case
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.
PMID 19266092·PLoS One·2009
6-review
A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study.
PMID 18782780·J Antimicrob Chemother·2008
4-observational
Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.
PMID 18205802·Haemophilia·2008
8-other
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
PMID 18549313·Clin Infect Dis·2008
6-review
Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
PMID 17999972·J Antimicrob Chemother·2008
8-other
Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.
PMID 18484978·HIV Med·2008
4-observational
Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
PMID 18753937·AIDS·2008
6-review
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
PMID 17973848·Haemophilia·2007
8-other
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
PMID 17197813·AIDS·2007
6-review
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.
PMID 17554216·J Acquir Immune Defic Syndr·2007
2-rct
In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1.
PMID 17638694·Antimicrob Agents Chemother·2007
8-other
Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy.
PMID 17072129·Pediatr Infect Dis J·2006
8-other
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.
PMID 16436728·Antimicrob Agents Chemother·2006
8-other
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.
PMID 16514293·AIDS·2006
4-observational
Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
PMID 16834736·Haemophilia·2006
8-other
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.
PMID 16928764·J Virol·2006
3-trial
Drug development strategies for salvage therapy: conflicts and solutions.
PMID 17147496·AIDS Res Hum Retroviruses·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 975 SERENO DR
VALLEJO, CA 94589 - Phone
- (707) 651-1000
Quick Facts
- NPI
- 1235217803
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile